Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000218526 | SCV000279659 | likely pathogenic | not provided | 2015-12-10 | criteria provided, single submitter | clinical testing | The L81V variant in the GJB1 gene has not been reported previously as a pathogenic variant, nor as abenign variant, to our knowledge. The L81V variant was not observed in approximately 6,500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The L81V variant is a conservativeamino acid substitution, which is not likely to impact secondary protein structure as these residuesshare similar properties. This substitution occurs at a position that is conserved across species. In silicoanalysis predicts this variant is probably damaging to the protein structure/function. Missense variantsin the same and nearby residues (Q80K, L81F, I82M, L83P, V84I, S85F) have been reported in theHuman Gene Mutation Database in association with Charcot-Marie-Tooth disease (Stenson et al.,2014), supporting the functional importance of this region of the protein. The L81V variant is astrong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. |